People with bladder cancer should seek out a urologist or healthcare facility that offers Blue Light Cystoscopy (BLC®), a procedure that uses both white and blue light for the examination inside the bladder. Visibility of bladder tumors is a critical factor in their removal in the operating room and in follow-up care in the office. The use of an FDA-approved optical imaging agent called Cysview® (hexaminolevulinate HCl) makes non-muscle invasive bladder cancer tumors glow pink in the blue light. Important Risk & Safety Information Cysview ® (hexaminolevulinate HCl) is an optical imaging agent used to detect non-muscle invasive bladder cancer in patients suspected or known to have lesion(s) on the basis of a prior cystoscopy, or in patients undergoing surveillance cystoscopy for bladder cancer. Cysview is not a replacement for random bladder biopsies or other procedures used in the detection of bladder cancer. Anaphylactoid shock, hypersensitivity reactions, bladder pain, bladder inflam
